Robust protein-based engineering of hepatocyte-like cells from human mesenchymal stem cells

Background: Cells of interest can be prepared from somatic cells by forced expression of lineage-specific transcription factors, but it is required to establish a vector-free system for their clinical use. Here, we report a protein-based artificial transcription system for engineering hepatocyte-like cells from human umbilical cord-derived mesenchymal stem cells (MSCs). Methods: MSCs were treated for 5 days with 4 artificial transcription factors (4F), which targeted hepatocyte nuclear factor (HNF)1α, HNF3γ, HNF4α, and GATA-binding protein 4 (GATA4). Then, engineered MSCs (4F-Heps) were subjected to epigenetic analysis, biochemical analysis and flow cytometry analysis with antibodies to marker proteins of mature hepatocytes and hepatic progenitors such as delta-like homolog 1 (DLK1) and trophoblast cell surface antigen 2 (TROP2). Functional properties of the cells were also examined by injecting them to mice with lethal hepatic failure. Results: Epigenetic analysis revealed that a 5-day treatment of 4F upregulated the expression of genes involved in hepatic differentiation, and repressed genes related to pluripotency of MSCs. Flow cytometry analysis detected that 4F-Heps were composed of small numbers of mature hepatocytes (at most 1%), bile duct cells (~19%) and hepatic progenitors (~50%). Interestingly, ~20% of 4F-Heps were positive for cytochrome P450 3A4, 80% of which were DLK1-positive. Injection of 4F-Heps significantly increased survival of mice with lethal hepatic failure, and transplanted 4F-Heps expanded to more than 50-fold of human albumin-positive cells in the mouse livers, well consistent with the observation that 4F-Heps contained DLK1-positive and/or TROP2-positive cells. Conclusion: Taken together with observations that 4F-Heps were not tumorigenic in immunocompromised mice for at least 2 years, we propose that this artificial transcription system is a versatile tool for cell therapy for hepatic failures.

[1]  Harukazu Suzuki,et al.  GATA6 is predicted to regulate DNA methylation in an in vitro model of human hepatocyte differentiation , 2022, Communications Biology.

[2]  Natalie Porat-Shliom,et al.  Liver Zonation – Revisiting Old Questions With New Technologies , 2021, Frontiers in Physiology.

[3]  S. Duncan,et al.  GATA6 defines endoderm fate by controlling chromatin accessibility during differentiation of human-induced pluripotent stem cells , 2021, Cell reports.

[4]  T. Vanhaecke,et al.  Direct reprogramming of somatic cells into induced hepatocytes: cracking the Enigma code. , 2021, Journal of hepatology.

[5]  D. Pei,et al.  Challenges and advances in clinical applications of mesenchymal stromal cells , 2021, Journal of Hematology & Oncology.

[6]  I. Goldstein,et al.  Protocol for Primary Mouse Hepatocyte Isolation , 2020, STAR protocols.

[7]  S. Shamdani,et al.  Different approaches for transformation of mesenchymal stem cells into hepatocyte-like cells , 2020, Stem Cell Research & Therapy.

[8]  Meiyan Sun,et al.  Stem Cell-Based Therapies for Liver Diseases: An Overview and Update , 2019, Tissue Engineering and Regenerative Medicine.

[9]  M. Shimura,et al.  Identification of a cell-penetrating peptide applicable to a protein-based transcription activator-like effector expression system for cell engineering. , 2018, Biomaterials.

[10]  Y. Ishizaka,et al.  Advances in direct reprogramming and its future clinical application using a protein-based cell engineering system , 2018 .

[11]  Emilia Dimitrova,et al.  Histone demethylases in chromatin biology and beyond , 2015, EMBO reports.

[12]  G. Song,et al.  Generation of integration-free induced hepatocyte-like cells from mouse fibroblasts , 2015, Scientific Reports.

[13]  C. Byrne,et al.  NAFLD: a multisystem disease. , 2015, Journal of hepatology.

[14]  Ron Weiss,et al.  Highly-efficient Cas9-mediated transcriptional programming , 2014, Nature Methods.

[15]  Ying Zhang,et al.  Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. , 2014, Cell stem cell.

[16]  J. Shu,et al.  Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming. , 2014, Cell stem cell.

[17]  L. Benet,et al.  Mouse liver repopulation with hepatocytes generated from human fibroblasts , 2014, Nature.

[18]  Ran Tao,et al.  Hepatocyte differentiation of mesenchymal stem cells. , 2012, Hepatobiliary & pancreatic diseases international : HBPD INT.

[19]  J. Carroll,et al.  Pioneer transcription factors: establishing competence for gene expression. , 2011, Genes & development.

[20]  L. Hui,et al.  Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors , 2011, Nature.

[21]  R. Takimoto,et al.  Iron chelator deferasirox rescued mice from Fas‐induced fulminant hepatitis , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[22]  Jens Boch,et al.  Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors , 2009, Science.

[23]  Matthew J. Moscou,et al.  A Simple Cipher Governs DNA Recognition by TAL Effectors , 2009, Science.

[24]  G. Rousseau,et al.  The Onecut transcription factors HNF-6/OC-1 and OC-2 regulate early liver expansion by controlling hepatoblast migration. , 2007, Developmental biology.

[25]  Fan Zhang,et al.  Gcn5 promotes acetylation, eviction, and methylation of nucleosomes in transcribed coding regions. , 2007, Molecular cell.

[26]  D. Tosh,et al.  The Wnt/β‐catenin pathway: master regulator of liver zonation? , 2006 .

[27]  K. Zaret,et al.  Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. , 2006, Developmental biology.

[28]  Klaus H. Kaestner,et al.  The initiation of liver development is dependent on Foxa transcription factors , 2005, Nature.

[29]  A. Miyajima,et al.  Isolation of hepatoblasts based on the expression of Dlk/Pref-1 , 2003, Journal of Cell Science.

[30]  G. Oliver,et al.  Prox1 is an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm , 2002, Mechanisms of Development.

[31]  T. Roskams,et al.  The onecut transcription factor HNF6 is required for normal development of the biliary tract. , 2002, Development.

[32]  Frank R. Lin,et al.  Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. , 2002, Molecular cell.

[33]  H. Yonekawa,et al.  Diphtheria toxin receptor–mediated conditional and targeted cell ablation in transgenic mice , 2001, Nature Biotechnology.

[34]  N. L. La Thangue,et al.  p300/CBP proteins: HATs for transcriptional bridges and scaffolds. , 2001, Journal of cell science.

[35]  S. Duncan,et al.  Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. , 2000, Genes & development.

[36]  D J Segal,et al.  Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. Morrisey,et al.  GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo. , 1998, Genes & development.

[38]  V. Factor,et al.  Hepatocytes Deficient in CCAAT/Enhancer Binding Protein α (C/EBPα) Exhibit both Hepatocyte and Biliary Epithelial Cell Character , 1998 .

[39]  U. Schibler,et al.  Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4. , 1991, Genes & development.

[40]  S. McKnight,et al.  Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. , 1988, Genes & development.

[41]  D. Tosh,et al.  The Wnt/beta-catenin pathway: master regulator of liver zonation? , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[42]  K. Lindros,et al.  Zonation of hepatic cytochrome P-450 expression and regulation. , 1998, The Biochemical journal.

[43]  V. Factor,et al.  Hepatocytes deficient in CCAAT/enhancer binding protein alpha (C/EBP alpha) exhibit both hepatocyte and biliary epithelial cell character. , 1998, Biochemical and biophysical research communications.